Global Point-of-Care or Rapid Diagnostics Market Research Report 2021

Global Point-of-Care or Rapid Diagnostics Market Research Report 2021

Table of Contents
1 Point-Of-Care Or Rapid Diagnostics Market Overview
1.1 Product Overview and Scope of Point-Of-Care Or Rapid Diagnostics
1.2 Point-Of-Care Or Rapid Diagnostics Segment by Type
1.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
1.3 Point-Of-Care Or Rapid Diagnostics Segment by Application
1.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Independent Laboratories
1.3.5 Others
1.4 Global Point-Of-Care Or Rapid Diagnostics Market Size Estimates and Forecasts
1.4.1 Global Point-Of-Care Or Rapid Diagnostics Revenue 2016-2027
1.4.2 Global Point-Of-Care Or Rapid Diagnostics Sales 2016-2027
1.4.3 Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2016 Versus 2021 Versus 2027
2 Point-Of-Care Or Rapid Diagnostics Market Competition by Manufacturers
2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Point-Of-Care Or Rapid Diagnostics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Point-Of-Care Or Rapid Diagnostics Manufacturing Sites, Area Served, Product Type
2.5 Point-Of-Care Or Rapid Diagnostics Market Competitive Situation and Trends
2.5.1 Point-Of-Care Or Rapid Diagnostics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue
2.5.3 Global Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario by Region
3.1 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.3.1 North America Point-Of-Care Or Rapid Diagnostics Sales by Country
3.3.2 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.4.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country
3.4.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Region
3.5.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region
3.5.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.6.1 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country
3.6.2 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
3.7.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country
3.7.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Point-Of-Care Or Rapid Diagnostics Historic Market Analysis by Type
4.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2016-2021)
4.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2016-2021)
4.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2021)
5 Global Point-Of-Care Or Rapid Diagnostics Historic Market Analysis by Application
5.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2016-2021)
5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2016-2021)
5.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Danaher
6.3.1 Danaher Corporation Information
6.3.2 Danaher Description and Business Overview
6.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.3.5 Danaher Recent Developments/Updates
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Corporation Information
6.4.2 Siemens Healthcare Description and Business Overview
6.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.4.5 Siemens Healthcare Recent Developments/Updates
6.5 Bio-Rad Laboratories
6.5.1 Bio-Rad Laboratories Corporation Information
6.5.2 Bio-Rad Laboratories Description and Business Overview
6.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.5.5 Bio-Rad Laboratories Recent Developments/Updates
6.6 BioMerieux
6.6.1 BioMerieux Corporation Information
6.6.2 BioMerieux Description and Business Overview
6.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.6.5 BioMerieux Recent Developments/Updates
6.7 Nova Biomedical
6.6.1 Nova Biomedical Corporation Information
6.6.2 Nova Biomedical Description and Business Overview
6.6.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.7.5 Nova Biomedical Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Corporation Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Quidel
6.9.1 Quidel Corporation Information
6.9.2 Quidel Description and Business Overview
6.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.9.5 Quidel Recent Developments/Updates
6.10 A. Menarini Diagnostics
6.10.1 A. Menarini Diagnostics Corporation Information
6.10.2 A. Menarini Diagnostics Description and Business Overview
6.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.10.5 A. Menarini Diagnostics Recent Developments/Updates
6.11 Becton Dickinson
6.11.1 Becton Dickinson Corporation Information
6.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.11.5 Becton Dickinson Recent Developments/Updates
6.12 Biosurfit
6.12.1 Biosurfit Corporation Information
6.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.12.5 Biosurfit Recent Developments/Updates
6.13 Astrego Diagnostics
6.13.1 Astrego Diagnostics Corporation Information
6.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.13.5 Astrego Diagnostics Recent Developments/Updates
6.14 Werfen
6.14.1 Werfen Corporation Information
6.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.14.5 Werfen Recent Developments/Updates
6.15 Abionic
6.15.1 Abionic Corporation Information
6.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.15.5 Abionic Recent Developments/Updates
6.16 Palex Medical/Bülhmann
6.16.1 Palex Medical/Bülhmann Corporation Information
6.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.16.5 Palex Medical/Bülhmann Recent Developments/Updates
6.17 Horiba Medical
6.17.1 Horiba Medical Corporation Information
6.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.17.5 Horiba Medical Recent Developments/Updates
6.18 RAL
6.18.1 RAL Corporation Information
6.18.2 RAL Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.18.5 RAL Recent Developments/Updates
6.19 Vircell
6.19.1 Vircell Corporation Information
6.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.19.5 Vircell Recent Developments/Updates
6.20 Monlab
6.20.1 Monlab Corporation Information
6.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.20.5 Monlab Recent Developments/Updates
6.21 Binding Site
6.21.1 Binding Site Corporation Information
6.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Description and Business Overview
6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
6.21.5 Binding Site Recent Developments/Updates
7 Point-Of-Care Or Rapid Diagnostics Manufacturing Cost Analysis
7.1 Point-Of-Care Or Rapid Diagnostics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics
7.4 Point-Of-Care Or Rapid Diagnostics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Point-Of-Care Or Rapid Diagnostics Distributors List
8.3 Point-Of-Care Or Rapid Diagnostics Customers
9 Point-Of-Care Or Rapid Diagnostics Market Dynamics
9.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
9.2 Point-Of-Care Or Rapid Diagnostics Growth Drivers
9.3 Point-Of-Care Or Rapid Diagnostics Market Challenges
9.4 Point-Of-Care Or Rapid Diagnostics Market Restraints
10 Global Market Forecast
10.1 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Type (2022-2027)
10.2 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Application (2022-2027)
10.3 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Point-Of-Care Or Rapid Diagnostics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Point-Of-Care Or Rapid Diagnostics by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Point-Of-Care Or Rapid Diagnostics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Point-Of-Care Or Rapid Diagnostics Covered in This Study
Table 5. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Point-Of-Care Or Rapid Diagnostics Average Price (US$/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Point-Of-Care Or Rapid Diagnostics Manufacturing Sites and Area Served
Table 11. Manufacturers Point-Of-Care Or Rapid Diagnostics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Point-Of-Care Or Rapid Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-Of-Care Or Rapid Diagnostics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021) & (K Doses)
Table 16. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Table 17. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 19. North America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 20. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 22. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 24. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 32. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 38. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Type (2016-2021)
Table 39. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2016-2021)
Table 40. Global Point-Of-Care Or Rapid Diagnostics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Type (2016-2021)
Table 42. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Type (2016-2021)
Table 43. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Application (2016-2021)
Table 44. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2016-2021)
Table 45. Global Point-Of-Care Or Rapid Diagnostics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Application (2016-2021)
Table 47. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 51. Roche Point-Of-Care Or Rapid Diagnostics Product
Table 52. Roche Recent Developments/Updates
Table 53. Abbott Corporation Information
Table 54. Abbott Description and Business Overview
Table 55. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 56. Abbott Point-Of-Care Or Rapid Diagnostics Product
Table 57. Abbott Recent Developments/Updates
Table 58. Danaher Corporation Information
Table 59. Danaher Description and Business Overview
Table 60. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 61. Danaher Point-Of-Care Or Rapid Diagnostics Product
Table 62. Danaher Recent Developments/Updates
Table 63. Siemens Healthcare Corporation Information
Table 64. Siemens Healthcare Description and Business Overview
Table 65. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 66. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product
Table 67. Siemens Healthcare Recent Developments/Updates
Table 68. Bio-Rad Laboratories Corporation Information
Table 69. Bio-Rad Laboratories Description and Business Overview
Table 70. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 71. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product
Table 72. Bio-Rad Laboratories Recent Developments/Updates
Table 73. BioMerieux Corporation Information
Table 74. BioMerieux Description and Business Overview
Table 75. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 76. BioMerieux Point-Of-Care Or Rapid Diagnostics Product
Table 77. BioMerieux Recent Developments/Updates
Table 78. Nova Biomedical Corporation Information
Table 79. Nova Biomedical Description and Business Overview
Table 80. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 81. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product
Table 82. Nova Biomedical Recent Developments/Updates
Table 83. Thermo Fisher Scientific Corporation Information
Table 84. Thermo Fisher Scientific Description and Business Overview
Table 85. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 86. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product
Table 87. Thermo Fisher Scientific Recent Developments/Updates
Table 88. Quidel Corporation Information
Table 89. Quidel Description and Business Overview
Table 90. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 91. Quidel Point-Of-Care Or Rapid Diagnostics Product
Table 92. Quidel Recent Developments/Updates
Table 93. A. Menarini Diagnostics Corporation Information
Table 94. A. Menarini Diagnostics Description and Business Overview
Table 95. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 96. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product
Table 97. A. Menarini Diagnostics Recent Developments/Updates
Table 98. Becton Dickinson Corporation Information
Table 99. Becton Dickinson Description and Business Overview
Table 100. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 101. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product
Table 102. Becton Dickinson Recent Developments/Updates
Table 103. Biosurfit Corporation Information
Table 104. Biosurfit Description and Business Overview
Table 105. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 106. Biosurfit Point-Of-Care Or Rapid Diagnostics Product
Table 107. Biosurfit Recent Developments/Updates
Table 108. Astrego Diagnostics Corporation Information
Table 109. Astrego Diagnostics Description and Business Overview
Table 110. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 111. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product
Table 112. Astrego Diagnostics Recent Developments/Updates
Table 113. Werfen Corporation Information
Table 114. Werfen Description and Business Overview
Table 115. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 116. Werfen Point-Of-Care Or Rapid Diagnostics Product
Table 117. Werfen Recent Developments/Updates
Table 118. Abionic Corporation Information
Table 119. Abionic Description and Business Overview
Table 120. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 121. Abionic Point-Of-Care Or Rapid Diagnostics Product
Table 122. Abionic Recent Developments/Updates
Table 123. Palex Medical/Bülhmann Corporation Information
Table 124. Palex Medical/Bülhmann Description and Business Overview
Table 125. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 126. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product
Table 127. Palex Medical/Bülhmann Recent Developments/Updates
Table 128. Horiba Medical Corporation Information
Table 129. Horiba Medical Description and Business Overview
Table 130. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 131. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product
Table 132. Horiba Medical Recent Developments/Updates
Table 133. RAL Corporation Information
Table 134. RAL Description and Business Overview
Table 135. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 136. RAL Point-Of-Care Or Rapid Diagnostics Product
Table 137. RAL Recent Developments/Updates
Table 138. Vircell Corporation Information
Table 139. Vircell Description and Business Overview
Table 140. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 141. Vircell Point-Of-Care Or Rapid Diagnostics Product
Table 142. Vircell Recent Developments/Updates
Table 143. Monlab Corporation Information
Table 144. Monlab Description and Business Overview
Table 145. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 146. Monlab Point-Of-Care Or Rapid Diagnostics Product
Table 147. Monlab Recent Developments/Updates
Table 148. Binding Site Corporation Information
Table 149. Binding Site Description and Business Overview
Table 150. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 151. Binding Site Point-Of-Care Or Rapid Diagnostics Product
Table 152. Binding Site Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Point-Of-Care Or Rapid Diagnostics Distributors List
Table 156. Point-Of-Care Or Rapid Diagnostics Customers List
Table 157. Point-Of-Care Or Rapid Diagnostics Market Trends
Table 158. Point-Of-Care Or Rapid Diagnostics Growth Drivers
Table 159. Point-Of-Care Or Rapid Diagnostics Market Challenges
Table 160. Point-Of-Care Or Rapid Diagnostics Market Restraints
Table 161. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2022-2027) & (K Doses)
Table 162. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Type (2022-2027)
Table 163. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 164. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Type (2022-2027)
Table 165. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2022-2027) & (K Doses)
Table 166. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Application (2022-2027)
Table 167. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 168. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Application (2022-2027)
Table 169. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2022-2027) & (K Doses)
Table 170. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Region (2022-2027)
Table 171. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 172. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Region (2022-2027)
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Point-Of-Care Or Rapid Diagnostics
Figure 2. Global Point-Of-Care Or Rapid Diagnostics Market Share by Type in 2020 & 2027
Figure 3. Intensive Care Product Picture
Figure 4. Covid-19 Testing Product Picture
Figure 5. Infectious Diseases Testing Product Picture
Figure 6. Cardiac Markers Testing Product Picture
Figure 7. Coagulation Testing Product Picture
Figure 8. Others Product Picture
Figure 9. Global Point-Of-Care Or Rapid Diagnostics Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Independent Laboratories
Figure 13. Others
Figure 14. Global Point-Of-Care Or Rapid Diagnostics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Point-Of-Care Or Rapid Diagnostics Market Size 2016-2027 (US$ Million)
Figure 16. Global Point-Of-Care Or Rapid Diagnostics Sales 2016-2027 (K Doses)
Figure 17. Global Point-Of-Care Or Rapid Diagnostics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Point-Of-Care Or Rapid Diagnostics Sales Share by Manufacturers in 2020
Figure 19. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Point-Of-Care Or Rapid Diagnostics Players: Market Share by Revenue in 2020
Figure 21. Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Figure 23. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region in 2020
Figure 24. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2016-2021)
Figure 25. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region in 2020
Figure 26. United States Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Ca

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs